John­son & John­son dri­ves pe­riph­er­al artery dis­ease aware­ness in new ‘Save Legs’ ini­tia­tive

Spurred by new claims da­ta, John­son & John­son’s Janssen is launch­ing a “ro­bust in­ter­ven­tion” around pe­riph­er­al artery dis­ease (PAD). The new “Save Legs. Change Lives” ef­fort aims to dri­ve ur­gency and ac­tion around the of­ten un­der-the-radar cir­cu­la­to­ry dis­ease.

The find­ings J&J said are con­cern­ing — culled from in­sur­ance claims da­ta — show that 61% of peo­ple in the US who un­der­go vas­cu­lar pro­ce­dures for PAD were un­aware that they had the con­di­tion. And al­though PAD is a known lead­ing cause of am­pu­ta­tion in the US, among pa­tients who un­der­go a leg am­pu­ta­tion an alarm­ing 70% die with­in three years.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER